Shashank Cingam, MD
Shashank Cingam, MD is an Assistant Professor, Division of Hematology/Oncology at University of New Mexico Comprehensive Cancer Center (UNMCCC). He completed his Hematology and Oncology fellowship at UNMCCC and a Bone marrow transplant/ Cell therapy fellowship at Stanford University. His primary focus is improving outcomes in patients with Myeloma and Lymphoma using novel cell and immunotherapies.
Mathew Fero, MD, FACP
My clinical and research interest is focused on the development of novel therapeutic agents for the treatment of hematological malignancies. Towards this aim, I am serving in several different capacities:
1) Director of the UNM Cell Therapy Program, which has brought hematopoietic stem cell transplantation and CAR T cell therapy to New Mexico.
2) Co-leader of the Hematology Clinical Working Group, which reviews and prioritizes clinical trials for hematological malignancies at UNM and affiliate NCORP community sites.
3) Director of UNM Cell Therapy laboratory which is developing methodologies for the processing and storage of hematopoietic stem cells and CAR T cells
4) Leader of the Fero research laboratory which has discovered non-RNA coding genes that interact with cell cycle regulators to cause hematological malignancies, with the potential as targets of new therapies for hematological malignancies, and diagnostic tests.
Amy Gundelach RN, MSN, AG-CNS-BC, OCN
Amy Gundelach, APRN, MSN, AG-CNS, OCN, is the program coordinator of the University of New Mexico Comprehensive Cancer Center's cancer survivorship program.
The program's mission is to improve the quality of life of cancer survivors at the UNM Cancer Center due to cancer and cancer treatments by focusing on the importance of improving functioning and helping survivors achieve optimal health and well-being by:
- Providing evidence-based information, resources and support to cancer survivors
- Increasing communication and collaboration with the survivor's primary care provider
- Offering survivorship clinic appointments to counsel patients on health promotion issues, along with disease and cancer treatment side-effects management.
Prior to her current position, Gundelach served as a nurse navigator for the Cancer Center's Gynecologic Oncology team, helping guide patients in their treatment and serving as a regular point of contact in their care.
Kelly Dunn RDN, CSO, CNSC, LD
Kelly Dunn, RDN, CSO, CNSC, LD, is board certified by the Academy of Nutrition and Dietetics in Oncology Nutrition.
Dunn has a bachelor's degree in nutrition science since 2002 and has completed 3,000 total hours of training to both be a registered dietician and to receive the oncology certification.
At the UNM Comprehensive Cancer Center, Dunn works with cancer treatment teams and patients to tailor a nutrition plan for each of her patients.
The goal of the plans is to keep patients nourished so they have the energy and strength to complete their treatments.
Dunn also works with care providers to reinforce the importance of dietitians and nutrition information for cancer patients.
